HOTH News and Press, Hoth Therapeutics Inc. From 11/30/21

Hoth Therapeutics' Enrollment and Dosing in Second Cohort in Phase 1b Human Trial for Atopic Dermatitis Under Way PR Newswire NEW YORK , Nov. 30, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused ...

Hoth Therapeutics (NASDAQ:HOTH) has signed a sponsored research agreement with North Carolina State University for the development of HT-KIT, an mRNA therapeutic for mast cell cancers. The research will center on characterizing the HT-KIT dose and  frequency for treatment of aggressive m...

Hoth Therapeutics Announces a Sponsored Research Agreement to Further Develop Novel mRNA Cancer Therapeutic HT-KIT PR Newswire NEW YORK , Nov. 16, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company, ...

Hoth Therapeutics Inks API and Drug Product Contracts with WuXi STA to Advance Manufacturing of HT-KIT Cancer Therapeutic WuXi STA, is a leading manufacturer of GMP morpholino oligonucleotides (PMOs) PR Newswire NEW YORK , Nov. 8, 2021 /PRNewswire/ -- H...

Hoth Therapeutics Extends Partnership Agreement with REPROCELL PR Newswire NEW YORK , Oct. 19, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc . (NASDAQ: HOTH) has extended its partnership agreement with REPROCELL to assess the effect of the HT-003 th...

Hoth Therapeutics Receives Approval to Commence Cohort 2 in Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis Patients PR Newswire NEW YORK , Oct. 12, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical compan...

Detroit, Michigan--(Newsfile Corp. - September 22, 2021) - Hoth Therapeutics, Inc. (NASDAQ: HOTH) will be presenting at the Benzinga Healthcare Small Cap Conference taking place on September 29-30, 2021. We invite our shareholders and all interested parties to explore healthcare small cap ...

Hoth Therapeutics Submits to Ethics Committee for Approval to Initiate Patient Cohort 2 in BioLexa Clinical Trial Marks final step toward initiating Cohort 2 of patients with mild-to-moderate eczema Based on the recommendations of the Safety Review Committee Hoth has submitt...

Hoth Therapeutics Announces Positive Phase 1b Results for Completed First Cohort of Patient Trial of BioLexa No serious adverse events and no drug-related treatment-emergent adverse events observed. BioLexa is a first in class treatment for Eczema PR Newswire N...

3 Penny Stocks to Watch as SPRT Stock Climbs Higher Penny stocks are climbing higher again as SPRT stock shows the meteoric potential of former small-caps. For those unfamiliar, Support.com Inc. ( NASDAQ: SPRT ) is a provider of customer support services. And while this alone is a p...